CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-06 | COLES N ANTHONY Director | Sale | −602 | $584.57 | $352K | 1,093 |
| 2022-09-06 | COLES N ANTHONY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,784 | 0 | ||
| 2022-09-06 | COLES N ANTHONY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,216 | 2,145 | ||
| 2022-09-01 | McCourt Marion EVP Commercial | Option exercise | +1,100 | $342.93 | $377K | 20,744 |
| 2022-09-01 | McCourt Marion EVP Commercial | Sale | −1,100 | $577.62 | $635K | 19,644 |
| 2022-09-01 | McCourt Marion EVP Commercial | Option exercise · Non-Qualified Stock Option (right to buy) | −1,100 | 500 | ||
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −76 | $639.85 | $49K | 61,907 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −148 | $640.91 | $95K | 61,759 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −537 | $641.47 | $344K | 61,222 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −329 | $642.53 | $211K | 60,893 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −94 | $643.37 | $60K | 60,799 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −332 | $644.49 | $214K | 60,467 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −119 | $645.63 | $77K | 60,348 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −325 | $646.44 | $210K | 60,023 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −701 | $647.73 | $454K | 59,322 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −766 | $648.78 | $497K | 58,556 |
| 2022-08-16 | MURPHY ANDREW J EVP Research | Sale | −86 | $649.54 | $56K | 58,470 |
| 2022-08-15 | MURPHY ANDREW J EVP Research | Option exercise | +10,000 | $179.13 | $1.8M | 68,470 |
| 2022-08-15 | MURPHY ANDREW J EVP Research | Shares withheld for taxes | −6,487 | $634.25 | $4.1M | 61,983 |
| 2022-08-15 | MURPHY ANDREW J EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) | −10,000 | 10,000 |
Page 75 of 105 · 2,088 trades